Sven Olson

Sven Olson is an Associate Professor of Medicine at Oregon Health & Science University, specializing in hematology, thrombosis, and hemostasis. His research focuses on venous thromboembolism, anticoagulant pharmacology, and vascular biology, with recent work examining Factor XI inhibition for catheter-associated thrombosis in cancer patients and desmopressin as a hemostatic agent in bleeding disorders. He has contributed to evidence-based consensus recommendations on iron deficiency management across pediatric, adult, and pregnant populations, published in *The Lancet Haematology*, and investigates the impact of electronic consultations on hematologic care delivery, including racial disparities in neutropenia referrals. His clinical interests extend to critical care and the optimization of anticoagulation strategies.